Zoghbi Huda Y — SEC insider filings

SEC reporting owner CIK 1681643. 12 insider filings on record with FilingPulse; latest filed 2026-11-05.

Transaction summary — filings shown

Covers all 12 filings on record, filed 2021-01-05 to 2026-11-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
REGENERON PHARMACEUTICALS, INC. (REGN)Director12—19 legs · 14,994 sh · $12,994,38828

Insider filings — Zoghbi Huda Y

FiledFormIssuerReported transactionsSource
2026-11-054REGENERON PHARMACEUTICALS, INC. (REGN)Option exercise (M): 7,439 @ $380.95 · Sale (S): 6,939 @ $970.42 · Sale (S): 500 @ $971.06 · Option exercise (M): 7,439 (derivative) @ $0EDGAR
2026-08-124REGENERON PHARMACEUTICALS, INC. (REGN)Option exercise (M): 800 @ $376.69 · Sale (S): 800 @ $800 · Option exercise (M): 800 (derivative) @ $0EDGAR
2026-02-234REGENERON PHARMACEUTICALS, INC. (REGN)Option exercise (M): 1,638 @ $376.69 · Sale (S): 49 @ $774.68 · Sale (S): 50 @ $775.50 · Sale (S): 53 @ $778.47 · Sale (S): 208 @ $779.55 · Sale (S): 331 @ $780.45 · +7 moreEDGAR
2026-01-064REGENERON PHARMACEUTICALS, INC. (REGN)Grant/award (A): 155 @ $0 · Grant/award (A): 1,962 (derivative) @ $0EDGAR
2025-01-064REGENERON PHARMACEUTICALS, INC. (REGN)Grant/award (A): 166 @ $0 · Grant/award (A): 1,958 (derivative) @ $0EDGAR
2024-01-044REGENERON PHARMACEUTICALS, INC. (REGN)Option exercise (M): 1,117 @ $391.92 · Sale (S): 1,117 @ $900 · Grant/award (A): 135 @ $0 · Option exercise (M): 1,117 (derivative) @ $0 · Grant/award (A): 1,607 (derivative) @ $0EDGAR
2023-10-174REGENERON PHARMACEUTICALS, INC. (REGN)Option exercise (M): 1,000 @ $391.92 · Sale (S): 1,000 @ $850 · Option exercise (M): 1,000 (derivative) @ $0EDGAR
2023-01-054REGENERON PHARMACEUTICALS, INC. (REGN)Grant/award (A): 165 @ $0 · Grant/award (A): 1,929 (derivative) @ $0EDGAR
2022-03-184REGENERON PHARMACEUTICALS, INC. (REGN)Option exercise (M): 2,000 @ $391.92 · Sale (S): 2,000 @ $675 · Option exercise (M): 2,000 (derivative) @ $0EDGAR
2022-01-054REGENERON PHARMACEUTICALS, INC. (REGN)Grant/award (A): 191 @ $0 · Grant/award (A): 2,707 (derivative) @ $0EDGAR
2021-09-154REGENERON PHARMACEUTICALS, INC. (REGN)Option exercise (M): 2 @ $391.92 · Sale (S): 2 @ $651.10 · Option exercise (M): 998 @ $391.92 · Sale (S): 998 @ $650 · Option exercise (M): 2 (derivative) @ $0 · Option exercise (M): 998 (derivative) @ $0EDGAR
2021-01-054REGENERON PHARMACEUTICALS, INC. (REGN)Grant/award (A): 248 @ $0 · Grant/award (A): 3,613 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-01-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1681643 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs